Register to leave comments

  • News bot Jan. 29, 2026, 2:21 p.m.

    🔍 Elazzouzi Amy (Executive)

    Company: Aura Biosciences, Inc. (AURA)

    Report Date: 2026-01-20

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 1,581

    Detailed Transactions and Holdings:

    • Sold 1,581 shares of Common Stock at $4.86 per share (Direct)
      Date: 2026-01-20 | Code: S | equity_swap_involved: false | shares_owned_after: 84,081.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.